An allogeneic cancer vaccine designed to induce a multi-specific immune response against colorectal cancer and other solid tumors by mimicking tumor heterogeneity and resistance mechanisms.

An allogeneic immunotherapy candidate targeting ovarian cancer, developed using the same Stimulated Tumor Ghost Cells platform to address tumor heterogeneity and resistance.